Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenters Clinical Cohort Study of the Efficacy and Safety of Stratified Risk Factors for Treatment of Chinese Children With Systemic ALK-positive Anaplastic Large Cell Lymphoma

NCT03971305 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03971305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03971305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenters Clinical Cohort Study of the Efficacy and Safety of Stratified Risk Factors for Treatment of Chinese Children With Systemic ALK-positive Anaplastic Large Cell Lymphoma
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
May 5, 2017
Completion date
May 5, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic lymphoma, lymphoma, nonhodgkin, mdd, mrd, pediatric cancer